WallStreetZenWallStreetZen

NASDAQ: INMD
Inmode Ltd Stock Forecast, Predictions & Price Target

Analyst price target for INMD

Based on 3 analysts offering 12 month price targets for Inmode Ltd.
Min Forecast
$16.00-3.9%
Avg Forecast
$20.67+24.13%
Max Forecast
$27.00+62.16%

Should I buy or sell INMD stock?

Based on 3 analysts offering ratings for Inmode Ltd.
Buy
Strong Buy
1 analysts 33.33%
Buy
0 analysts 0%
Hold
2 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their INMD stock forecasts and price targets.

INMD stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-10-14
lockedlocked$00.00+00.00%2024-07-23
lockedlocked$00.00+00.00%2024-07-12

1 of 1

Forecast return on equity

Is INMD forecast to generate an efficient return?
Company
N/A
Industry
21.4%
Market
52.42%

Forecast return on assets

Is INMD forecast to generate an efficient return on assets?
Company
N/A
Industry
11.48%

INMD earnings per share forecast

What is INMD's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$1.63-8.43%
Avg 2 year Forecast
$1.94+8.99%
INMD's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

INMD revenue forecast

What is INMD's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$408.8M-1.88%
Avg 2 year Forecast
$430.1M+3.23%
Avg 3 year Forecast
$451.4M+8.35%
INMD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

INMD earnings growth forecast

How is INMD forecast to perform vs Medical Devices companies and vs the US market?
Company
4.4%
Industry
35.72%
Market
20.11%
INMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
INMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
INMD's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

INMD revenue growth forecast

How is INMD forecast to perform vs Medical Devices companies and vs the US market?
Company
1.6%
Industry
6.84%
Market
8.81%
INMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
INMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

INMD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
INMD$16.65$20.67+24.13%Buy
AHCO$10.02$13.00+29.74%Strong Buy
IART$19.22$23.14+20.41%Sell
ESTA$41.28$60.60+46.80%Strong Buy
AORT$26.20$30.00+14.50%Strong Buy

Inmode Stock Forecast FAQ

Is Inmode Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: INMD) stock is to Buy INMD stock.

Out of 3 analysts, 1 (33.33%) are recommending INMD as a Strong Buy, 0 (0%) are recommending INMD as a Buy, 2 (66.67%) are recommending INMD as a Hold, 0 (0%) are recommending INMD as a Sell, and 0 (0%) are recommending INMD as a Strong Sell.

If you're new to stock investing, here's how to buy Inmode stock.

What is INMD's earnings growth forecast for 2024-2025?

(NASDAQ: INMD) Inmode's forecast annual earnings growth rate of 4.4% is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 35.72%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 20.11%.

Inmode's earnings in 2024 is $149,199,000.On average, 1 Wall Street analyst forecast INMD's earnings for 2024 to be $137,772,490, with the lowest INMD earnings forecast at $137,772,490, and the highest INMD earnings forecast at $137,772,490.

In 2025, INMD is forecast to generate $163,974,620 in earnings, with the lowest earnings forecast at $163,974,620 and the highest earnings forecast at $163,974,620.

What is INMD's revenue growth forecast for 2024-2026?

(NASDAQ: INMD) Inmode's forecast annual revenue growth rate of 1.6% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.84%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 8.81%.

Inmode's revenue in 2024 is $416,626,000.On average, 1 Wall Street analysts forecast INMD's revenue for 2024 to be $34,553,002,400, with the lowest INMD revenue forecast at $34,553,002,400, and the highest INMD revenue forecast at $34,553,002,400. On average, 1 Wall Street analysts forecast INMD's revenue for 2025 to be $36,353,342,300, with the lowest INMD revenue forecast at $36,353,342,300, and the highest INMD revenue forecast at $36,353,342,300.

In 2026, INMD is forecast to generate $38,153,682,200 in revenue, with the lowest revenue forecast at $38,153,682,200 and the highest revenue forecast at $38,153,682,200.

What is INMD's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: INMD) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 11.48%.

What is INMD's Price Target?

According to 3 Wall Street analysts that have issued a 1 year INMD price target, the average INMD price target is $20.67, with the highest INMD stock price forecast at $27.00 and the lowest INMD stock price forecast at $16.00.

On average, Wall Street analysts predict that Inmode's share price could reach $20.67 by Oct 14, 2025. The average Inmode stock price prediction forecasts a potential upside of 24.13% from the current INMD share price of $16.65.

What is INMD's Earnings Per Share (EPS) forecast for 2024-2025?

(NASDAQ: INMD) Inmode's current Earnings Per Share (EPS) is $1.78. On average, analysts forecast that INMD's EPS will be $1.63 for 2024, with the lowest EPS forecast at $1.63, and the highest EPS forecast at $1.63. In 2025, INMD's EPS is forecast to hit $1.94 (min: $1.94, max: $1.94).

What is INMD's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: INMD) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.